Table 2.

Examples of predicted breakpoints in breast tumor aCGH case study. Listing of Unigene IDs corresponding to predicted breakpoints for ChARMView results pictured in Figures 6A and 6B. The Unigene ID and gene name are the first and last markers included in the predicted amplification. All results listed have Bonferroni-corrected less than p-values of .05 for both mean and sign significance tests.

Tumor sample	Chrom.	Predicted start breakpoint	Adjacent gene (in amplicon)	Predicted end breakpoint	Adjacent gene (in amplicon)
110B	1	Hs.15871	ACP6	Hs.7395 (last marker)	TFB2M
112B	1	Hs.59889	HMGCS2	Hs.7395 (last marker)	TFB2M
122A	1	Hs.381235	SEC22L1	Hs.7395 (last marker)	TFB2M
123B	17	Hs.97477	LYZL6	Hs.276916	NR1D1
309A	17	Hs.73817	CCL18	Hs.267871	PTRF1
BC-A	17	Hs.635	CACNB1	Hs.2340	HAP1